Active Ingredient History
Fresh frozen plasma (FFP) is a blood product made from the liquid portion of whole blood. It is used to treat conditions in which there are low blood clotting factors or low levels of other blood proteins. It may also be used as the replacement fluid in plasma exchange. Using ABO compatible plasma, while not required, may be recommended. Use as a volume expander is not recommended. It is administered by slow injection into a vein. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acute Kidney Injury (Phase 3)
Acute-On-Chronic Liver Failure (Phase 3)
Aging (Phase 1)
Alzheimer Disease (Phase 2)
Amyotrophic Lateral Sclerosis (Early Phase 1)
Aneurysm, Ruptured (Phase 4)
Angioedema (Phase 2)
Anticoagulants (Phase 3)
Anticoagulation Reversal (Phase 2)
Aortic Aneurysm, Thoracic (Phase 4)
Ascites (Phase 2)
Bleeding Time (Phase 4)
Blood (Phase 4)
Blood Coagulation (Phase 4)
Blood Coagulation Disorders (Phase 4)
Blood Loss, Surgical (Phase 4)
Blood Transfusion (Phase 2)
Brain Injuries, Traumatic (Phase 2/Phase 3)
Bronchiectasis (Phase 4)
Burns (Phase 4)
Cardiac Surgical Procedures (Phase 4)
Cardiovascular Surgical Procedures (Phase 4)
Cerebral Hemorrhage (Phase 2)
Cognitive Dysfunction (Phase 1)
Communicable Diseases (Phase 3)
Contrast Media (Phase 3)
Coronary Artery Disease (Phase 4)
Coronavirus (Phase 2/Phase 3)
Coronavirus Infections (Phase 2/Phase 3)
COVID-19 (Phase 4)
Drugs, Investigational (Phase 1)
Endothelial Cells (Phase 4)
Fasciitis, Plantar (Phase 4)
Fibrin (Phase 3)
Frail Elderly (Early Phase 1)
Frailty (Early Phase 1)
General Surgery (Phase 4)
Glomerulonephritis (Phase 2/Phase 3)
Glomerulonephritis, IGA (Phase 2/Phase 3)
Glomerulosclerosis, Focal Segmental (Phase 1/Phase 2)
Graft Rejection (Phase 2)
Granulomatosis with Polyangiitis (Phase 2/Phase 3)
Growth and Development (Phase 1)
Healthy Volunteers (Phase 1)
Heart Defects, Congenital (Phase 2)
Heart Diseases (Phase 3)
Heart Failure (Phase 3)
Heart Valve Diseases (Phase 4)
Hemorrhage (Phase 4)
Hemorrhagic Fever, Ebola (Phase 1)
Idiopathic Pulmonary Fibrosis (Phase 1/Phase 2)
Intracranial Hemorrhages (Phase 4)
Kidney Diseases (Phase 2/Phase 3)
Kidney Transplantation (Phase 3)
Knee Injuries (Phase 4)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Liver Cirrhosis (Phase 2)
Liver Diseases (Phase 4)
Liver Transplantation (Phase 4)
Microscopic Polyangiitis (Phase 2/Phase 3)
Minimally Invasive Surgical Procedures (Phase 3)
Multiple Sclerosis (Early Phase 1)
Osteoarthritis, Hip (Phase 4)
Osteoarthritis, Knee (Phase 2)
Pancreatic Diseases (Phase 4)
Parkinson Disease (Phase 4)
Plasma (Phase 4)
Post-Acute COVID-19 Syndrome (Phase 2)
Prostatic Neoplasms (Phase 4)
Purpura (Phase 3)
Purpura, Thrombotic Thrombocytopenic (Phase 4)
Renal Insufficiency, Chronic (Phase 3)
Respiratory Distress Syndrome (Phase 2)
Shock, Hemorrhagic (Phase 4)
Shock, Septic (Phase 4)
Spinal Dysraphism (Phase 4)
Sports Medicine (Phase 3)
Sprains and Strains (Phase 4)
Stroke (Phase 2)
Supranuclear Palsy, Progressive (Phase 1)
Thoracic Surgery (Phase 4)
Thrombosis (Phase 4)
Transfusion Reaction (Phase 2)
Transfusion-Related Acute Lung Injury (Phase 2)
Traumatology (Phase 4)
Wounds and Injuries (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
